License and Collaboration Agreements (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2026	Mar. 31, 2026	Sep. 30, 2026
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Upfront and milestone payment			$ 29.0
Terminated Pre Clinical Program
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Upfront and milestone payment			25.0
MediLink Therapeutics | DLL3-Targeting ADC
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Milestone fee		$ 8.0
Maximum additional milestone payments			584.0
Pfizer | Tisotumab Vedotin
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Milestone fee	$ 10.0
Maximum additional milestone payments			$ 248.0